NICOLINI GABRIELLA

Tarasiuk, O., Molteni, L., Malacrida, A., Nicolini, G. (2024). The Role of NMNAT2/SARM1 in Neuropathy Development. BIOLOGY, 13(1) [10.3390/biology13010061]. Dettaglio

Malacrida, A., Tarasiuk, O., Rodriguez-Menendez, V., Stanga, S., Pero, M., Bartolini, F., et al. (2024). Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction. In Abstracts of the Fourteenth Annual Meeting of the Associazione italiana per lo studio del Sistema Nervoso Periferico (ASNP), 30 May – 1 June 2024, Trieste, Italy (pp.34-35). Wiley [10.1111/jns.12627]. Dettaglio

Rivara, M., Nicolini, G., Malacrida, A., Re, F., Incerti, M., Russo, G., et al. (2024). New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma. RESULTS IN CHEMISTRY, 9(July 2024) [10.1016/j.rechem.2024.101645]. Dettaglio

Giambra, M., Di Cristofori, A., Raimondo, F., Rigolio, R., Conconi, D., Chiarello, G., et al. (2024). Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25(5) [10.3390/ijms25052743]. Dettaglio

Meregalli, C., Malacrida, A., Pero, M., Rumora, A., Cartelli, D., Nicolini, G., et al. (2023). Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons. In 76° CONGRESSOdella Società Italiana di Anatomia e Istologia (pp.28-28). FIRENZE UNIVERSITY PRESS. Dettaglio